We recently wrote an article on a full-featured “detachable” tubeless insulin pump, Medingo’s Solo MicroPump Insulin Delivery System . We had previously mentioned that...

ASP1941 (SGLT2 inhibitor for type 2).

Over the past year, several of the world’s largest pharmaceutical companies have expanded their efforts to develop new diabetes therapies and devices. In late December,...

Taking Control of Your Diabetes (TCOYD) is continuing to offer its stellar conference series in 2010. These events – led by renowned endocrinologist, type 1 diabetes...

Teaching a child with type 1 diabetes the "facts of life"... Jim Hirsch reflects.

At the recent American Association of Diabetes Educators (AADE) conference in San Antonio, Texas, Tandem Diabetes Care unveiled its anticipated new insulin pump, the t:...

In a recent study, Novo Nordisk's next-generation basal insulin degludec was found to cause less hypoglycemia than Lantus. In early May, Novo Nordisk announced the...

We recently reviewed three drug candidates for the treatment of obesity – Contrave, lorcaserin, and Qnexa. All three drugs in development: they all have been submitted...

Canagliflozin (SGLT2 inhibitor for type 2)

We recently had the opportunity to watch a compelling documentary titled The Science of Inspiration, which chronicles the journeys of the twelve members of the inaugural...

Do insulin pumps always pump the same? Read on to learn more about the “siphon effect.”

Earlier this month, Eli Lilly and the German pharmaceutical Boehringer Ingelheim (BI) announced a major partnership to co-develop and co-commercialize several of their...

Kelly highlights an important diaTribe milestone and debriefs readers on the latest developments in diabetes technology.

In 2007, Dr. Steven Nissen and Kathy Wolski of the Cleveland Clinic published an analysis on the cardiovascular risk associated with Avandia (rosiglitazone) that sparked...

Obesity expert Dr. Lee Kaplan of Massachusetts General Hospital tells us how we may be able to bypass the bypass…

AADE spotlights self-management and patient-provider interactions.

Dexcom recently received CE Mark approval for its fourth-generation CGM sensor, clearing the new sensor for use in Europe. The company plans to first feature the sensor...

A company that has long been in “stealth mode,” Cellnovo recently emerged with a new discreet insulin pump. Dubbed the Cellnovo 150/Cellnovo 50 (the Cellnovo 150 holds...

Sometimes, it might seem like the only way mobile phones improve your doctor visits is by giving you a chance to text your friends from the waiting room. That could be...

(S)he said what?!?